Prognostic Value of Hemoglobin, Albumin, Lymphocyte, Platelet (HALP) Score in Patients with Metastatic Renal Cell Carcinoma Treated with Nivolumab

Prognostic Value of Hemoglobin, Albumin, Lymphocyte, Platelet (HALP) Score in Patients with Metastatic Renal Cell Carcinoma Treated with Nivolumab

<b>Background:</b> Immunotherapy based on checkpoint inhibition is widely used in the treatment of metastatic renal cell carcinoma (RCC); however, predictive and prognostic biomarkers are yet to be explored. The objective of this study was to evaluate the prognostic value of the hemoglob...

Celý popis

Podrobná bibliografie
Hlavní autoři: Zuzana Tomčová, Jana Obertová, Michal Chovanec, Zuzana Syčová-Milá, Katarína Štefániková, Eva Šlachtová, Monika Žák, Alexander Savka, Matej Hrnčár, Katarína Rejleková, Patrik Palacka
Médium: Článek
Jazyk:English
Vydáno: MDPI AG 2025-02-01
Edice:Biomedicines
Témata:
blood counts
albumin
renal cell carcinoma
metastatic disease
nivolumab
On-line přístup:https://www.mdpi.com/2227-9059/13/2/484

Internet

https://www.mdpi.com/2227-9059/13/2/484

Podobné jednotky